Therapy-related myeloid neoplasms following fludarabine, cyclophosphamide, and rituximab (FCR) treatment in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. [electronic resource]
Producer: 20120518Description: 237-45 p. digitalISSN:- 1530-0285
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Clinical Trials as Topic
- Cyclophosphamide -- administration & dosage
- Female
- Humans
- Incidence
- Kaplan-Meier Estimate
- Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
- Male
- Middle Aged
- Neoplasms, Second Primary -- chemically induced
- Retrospective Studies
- Rituximab
- Vidarabine -- administration & dosage
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.